🇺🇸 FDA
Patent

US 10335465

Mutant OPAA enzyme with increased catalytic efficiency on organophosphorus compound GP

granted A61KA61K38/465

Quick answer

US patent 10335465 (Mutant OPAA enzyme with increased catalytic efficiency on organophosphorus compound GP) held by The United States of America as represented by the Secretary of the Army expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/465